The NEJM study chose a much lower dose, 400mcg per day for only three days, less than half the total dose that has been shown to be effective By Madhava Setty, M.D. | The Defender | March 31, 2022 The New York Times on Wednesday sent an email blast to subscribers with the subject line: […]
Source